Biondo Investment Advisors LLC lessened its position in Core Laboratories (NYSE:CLB) by 7.1% in the 4th quarter, HoldingsChannel reports. The firm owned 35,707 shares of the oil and gas company’s stock after selling 2,720 shares during the period. Biondo Investment Advisors LLC’s holdings in Core Laboratories were worth $3,912,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of CLB. The Manufacturers Life Insurance Company increased its stake in Core Laboratories by 63.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 439 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its position in shares of Core Laboratories by 60.7% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 1,096 shares of the oil and gas company’s stock worth $120,000 after acquiring an additional 414 shares in the last quarter. Advisory Services Network LLC increased its position in shares of Core Laboratories by 33.3% during the second quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock worth $138,000 after acquiring an additional 341 shares in the last quarter. Toronto Dominion Bank increased its position in shares of Core Laboratories by 243.6% during the third quarter. Toronto Dominion Bank now owns 1,866 shares of the oil and gas company’s stock worth $184,000 after acquiring an additional 1,323 shares in the last quarter. Finally, Callahan Advisors LLC bought a new stake in shares of Core Laboratories during the fourth quarter worth $201,000.
Several equities research analysts have recently issued reports on the stock. TheStreet raised shares of Core Laboratories from a “c” rating to a “b-” rating in a research report on Thursday, February 1st. ABN Amro downgraded shares of Core Laboratories from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Royal Bank of Canada set a $125.00 price objective on shares of Core Laboratories and gave the stock a “buy” rating in a research report on Tuesday, January 30th. Piper Jaffray Companies set a $97.00 price objective on shares of Core Laboratories and gave the stock a “hold” rating in a research report on Monday, October 23rd. Finally, Deutsche Bank downgraded shares of Core Laboratories from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $116.30 to $109.00 in a research report on Thursday, January 11th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $111.70.
Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, January 31st. The oil and gas company reported $0.58 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.58. Core Laboratories had a net margin of 12.60% and a return on equity of 58.25%. The business had revenue of $172.00 million during the quarter, compared to analysts’ expectations of $171.92 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The firm’s revenue was up 15.1% on a year-over-year basis. analysts forecast that Core Laboratories will post 2.67 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 16th. Investors of record on Friday, January 26th will be issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 2.10%. The ex-dividend date of this dividend is Thursday, January 25th. Core Laboratories’s payout ratio is 117.02%.
COPYRIGHT VIOLATION NOTICE: “Core Laboratories (CLB) Holdings Reduced by Biondo Investment Advisors LLC” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.com-unik.info/2018/02/10/core-laboratories-clb-holdings-reduced-by-biondo-investment-advisors-llc.html.
Core Laboratories Company Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.